Form 483

Promeko, Inc. Form 483, 2013-11-21

FDA issued a Form 483 to Promeko, Inc. on 2013-11-21 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

Promeko, Inc. · West New York, United States · Issued November 21, 2013

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

21 Nov 2013
21 CFR 111.65

Quality control - quality, dietary supplement

Cited by Melba T Rivera Clavell

21 Nov 2013
21 CFR 211.22(a)

Lack of quality control unit

Cited by Melba T Rivera Clavell

21 Nov 2013
21 CFR 211.25(a)

Training--operations, GMPs, written procedures

Cited by Melba T Rivera Clavell

21 Nov 2013
21 CFR 211.84(d)(1)

Identity Testing of Each Component

Cited by Melba T Rivera Clavell

21 Nov 2013
21 CFR 211.84(d)(2)

Testing Each Component for Conformity with Specs

Cited by Melba T Rivera Clavell

Inspected site

PIPromeko, Inc.West New York, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 111.65Cited across public-safe Form 483 observations1x
21 CFR 211.198(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(a)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(1)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(2)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 6 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere